The ten finalists of the European Women Who Tech challenge have been announced, including a Falkirk- and London based BioTech firm.
Women Who Tech, one of the largest organizations that funds and showcases women-led ventures, announced the ten finalists for the European-leg of its Women Startup Challenge.
The HealthTech start-ups will pitch their ventures to top investors and compete for an equity-free $50,000 cash grant on 7th October at Paris City Hall, Hôtel de Ville.
London-based Arthronica, which provides a SaaS platform to remotely diagnose arthritis using a laptop or smartphone camera and AI, was one of two UK firms announced.
The company, founded by Letizia Gionfrida, provides rapid access to data on illness progression to optimize patient recovery pathways.
Falkirk-based uFraction8 was the second firm, founded by its CEO Monika Tomecka.
The Scottish firm develops novel filters to help bio-manufacturers, who grow biological cells including yeast, micro-algae, and mammalian cells for products including food and drink, feed, bio-chemicals, and medicines).
The firm harvests cells with sustainable and scalable technology, outcompeting conventional filters and centrifuges.
“By 2040, $25 trillion will be spent annually on healthcare, yet only 9.7 per cent of investor funding goes to women-led HealthTech startups,” said said Allyson Kapin, Founder of Women Who Tech.
“The Women Startup Challenge is fostering a culture and inclusive economy to accelerate women founders who are developing solutions to the biggest health problems, directly impacting people’s lives.
“The reality is that the playing field for women isn’t level when it comes to investor funding, and we intend to tackle this gap head on by providing these founders access to capital, resources, and a top-tier investor network.”
The complete lists of finalists are:
Arthronica – London, England: A SaaS platform to remotely diagnose arthritis using laptop/smartphone cameras combined with AI-powered software. They provide rapid access to data on illness progression to optimize patient recovery pathways.
Blazar – Paris, France: A platform to help oncologists and researchers predict patient responses to cancer immunotherapy treatments so people living with cancer can fight it more effectively.
Cardiomo – NYC, United States: An AI-based solution in cardiac patient monitoring. This wearable device and analytic system remotely monitors patient vitals using biosensors and AI to detect cardiac events with 99.63% accuracy, providing life-saving alerts.
Cyprio – Paris, France: Redefining 3D cell culture, Cyprio developed the “BioPearl technology”, a breakthrough in tissue engineering allowing the fabrication of 3D cellular models of human livers to provide better predictive research tools for drug efficacy and toxicity screening.
Eva – London, England: Developed a health app that helps people manage the effects of menopause combining behavioural science, symptom tracking, and personalized health insights.
FORTË – NYC, United States: A platform that provides access to boutique fitness studio classes coached by leading health and fitness experts worldwide. Both a technology and subscription-based streaming platform, FORTE¨ installs hardware and software into studios, which enables the classes to be streamed live daily.
Luma Womb – Paris, France: Harnessing low-level light therapy to increase fertility. Luma Womb’s patent-pending medical device helps solve infertility issues related to thin uterine lining by using photobiomodulation to regenerate it.
Meds²Go – Noordwijk, the Netherlands: Developed innovative and stylish cooling containers for people who rely on temperature-sensitive medicines. By extending the travel time (without charging) and measuring the temperature, the container gives people the freedom and security to travel.
uFraction8 – Falkirk, Scotland: Develops novel filters to help bio-manufacturers, who grow biological cells (yeast, bacteria, micro-algae, mammalian cells) for products (food and drink, feed, bio-chemicals, medicines), to harvest cells with sustainable and scalable technology outcompeting conventional filters and centrifuges.
Wellola – Dublin, Ireland: A SasS platform that’s revolutionizing how clinics care for and communicate with patients. Wellola’s white-label platform provides clinics with the technology to conduct patients’ secure e-visits and has built-in messaging systems, online payment processing, and more.